Self-insured employers and benefits professionals are facing a crisis. Each year, they see prescription drug spending increase at alarming rates. According to Conduent’s annual survey, 55
A decade ago, physicians who treat epilepsy got what seemed like a piece of good news: Eight companies had received federal approval to sell a
Insurers, employers, unions and government programs are not required to hire a PBM. Instead the vast majority choose to do so because PBMs have a
But even if there are dramatic changes in regulations and taxes, the basic foundations of employer-based health benefits are not likely to be challenged.
The rate of increase in the cost of employer-provided health benefits has moderated significantly in recent years. However, costs for specialty drugs — designed to
After a yearlong investigation into rising drug prices, the U.S. Senate Special Committee on Aging has released a report that seeks to provide solutions to
VIDEO: Pharma companies have broken their social contracts with patients by pricing drugs too high, says Dr. Kenneth Davis, President and CEO of Mt. Sinai
Cost containment has been a major aspect of the Affordable Care Act (ACA), with incentives for reducing hospital readmissions and pressure on drug formulary
